ABBA Therapeutics closed ”Seed B” financing round Basel, Switzerland – 20.08.2018 – ABBA Therapeutics successfully closed “Seed B” financing round with European investors. The raised fund will be used to accelerate the preclinical efficacy study with cutting-edge animal models and advance two lead candidates for clinical efficacy study. About ABBA Therapeutics ABBA Therapeutics is a […]